This suggests that, for the virus, targeting BST-2 as part of its resistance to type I IFNs takes precedence over protecting HIV-1-infected cells from NK cell responses, at least early in infection, when type I IFN responses play an important role in systemic viral control. This evidence concerns the gene BST2 and infection.